Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening.
T. Tanaka, A. Saito, T. Suzuki, Y. Miyamoto, K. Takayama, T. Okamoto, K. Moriishi
This study develops a stable SARS-CoV-2 replicon system for high-throughput antiviral screening under BSL2 conditions, demonstrating its utility with remdesivir and interferon-β.
bioRxiv · Dec 23, 2021Microbiology